INTRODUCTION: Molecular biology, by acting in the development of biotechnological drugs, such as Zidovudine and Sofosbuvir, offers significant innovations in modern pharmacology, providing more specific and effective therapies for complex diseases. These drugs, although promising, still face challenges related to high costs and limited accessibility. The field is constantly evolving, seeking to improve the specificity and sensitivity of therapies for better prognoses. GENERAL OBJECTIVE: To explore the applications of molecular biology in the production of new drugs and its impact on the creation of personalized treatments. METHODOLOGY: This work is a qualitative, exploratory bibliographic review, which analyzes 7 articles published between 2020 and 2024 on molecular biology correlated to drug development. The research used databases such as BVS, DrugBank, PubMed and others, applying rigorous criteria for their selection. RESULTS: This study analyzes the potential of molecular biology for the development of new drugs, highlighting techniques such as PCR, DNA sequencing and CRISPR/Cas9. A review highlights the importance of these approaches in personalizing therapies and identifying molecular targets, in addition to discussing the pharmacodynamics and pharmacokinetics of drugs. Advances in molecular pharmacology offer new opportunities for more targeted and specific treatments with several drugs in complex diseases. CONCLUSION: The integrative review highlighted the importance of molecular biology techniques, such as DNA sequencing, PCR and CRISPR/Cas9, in drug development and personalized medicine, demonstrating their effectiveness in the treatment of genetic and infectious diseases. It is urgent to carry out new studies to explore the interactions of these technologies and their clinical applications, evolving towards better pharmacological treatments.
Read full abstract